Every open market buy and sale of Vera Therapeutics, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are net sellers over the last 12 months: $250K bought and $8.6M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when VERA insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an VERA officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every VERA insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Marshall FordycePresident And CEO | Sale plan | 18,500 | $37.00 | $685K | 235,244 | Sep 17Form 4 |
| Sep 2, 2026 | Marshall FordycePresident And CEO | Sale plan | 18,500 | $35.12 | $650K | 235,244 | Sep 4Form 4 |
| Jul 7, 2026 | Marshall FordycePresident And CEO | Sale plan | 46,250 | $42.30 | $2M | 151,994 | Jul 9Form 4 |
| Jun 23, 2026 | Marshall FordycePresident And CEO | Sale plan | 18,500 | $37.93 | $702K | 198,244 | Jun 24Form 4 |
| May 12, 2026 | Marshall FordycePresident And CEO | Sale plan | 18,500 | $36.74 | $680K | 216,744 | May 13Form 4 |
| Apr 14, 2026 | Marshall FordycePresident And CEO | Sale plan | 22,951 | $44.05 | $1M | 235,244 | Apr 15Form 4 |
| Feb 23, 2026 | David Lee JohnsonCOO | Sale | 2,579 | $41.98 | $108K | 45,727 | Feb 25Form 4 |
| Feb 23, 2026 | William D. TurnerChief Regulatory Officer | Sale | 2,187 | $41.98 | $92K | 45,313 | Feb 25Form 4 |
| Feb 23, 2026 | Marshall FordycePresident And CEO | Sale | 16,925 | $41.98 | $711K | 257,163 | Feb 25Form 4 |
| Feb 23, 2026 | Joseph R YoungSvp, Finance, Chief Acct Offcr | Sale | 3,117 | $41.98 | $131K | 64,722 | Feb 25Form 4 |
| Feb 23, 2026 | Sean GrantCFO | Sale | 4,949 | $41.98 | $208K | 114,181 | Feb 25Form 4 |
| Feb 23, 2026 | Robert BrennerChief Medical Officer | Sale | 2,151 | $41.98 | $90K | 50,947 | Feb 25Form 4 |
| Feb 23, 2026 | Laurence Matthew SkeltonChief Commercial Officer | Sale | 1,582 | $41.98 | $66K | 64,218 | Feb 25Form 4 |
| Dec 15, 2025 | William D. TurnerChief Regulatory Officer | Sale plan | 10,000 | $50.08 | $501K | 22,500 | Dec 17Form 4 |
| Dec 11, 2025 | Patrick G EnrightDirector | Buy | 5,882 | $42.50 | $250K | 5,882 | Dec 15Form 4 |
VERA insider trading FAQ
Are VERA insiders buying or selling?
Insiders are net sellers over the last 12 months. 1 insiders bought $250K of VERA on the open market in 1 trades, and 8 sold $8.6M in 17 trades, 82% of that under pre-arranged trading plans.
When did an VERA insider last buy shares?
Patrick G Enright (Director) bought 5,882 shares for $250K on Dec 11, 2025, reported on Dec 15, 2025.
When did an VERA insider last sell shares?
Marshall Fordyce (President And CEO) sold 18,500 shares for $685K on Sep 15, 2026, under a pre-arranged trading plan.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
